The number of people with susceptibility test result for rifampicin in Uruguay
Uruguay: The number of people with susceptibility test result for rifampicin was 80.19 in 2021. ▼ Falling
Latest (2021)
80.19
Change on year
up 0.1%
World rank
93rd
of 146 countries
All-time high
88.12
in 2018
All-time low
79.12
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Uruguay, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Uruguay recorded 80.19 for the number of people with susceptibility test result for rifampicin in 2021.
That represents a change of up 0.1% on the previous year and down 4.6% over five years.
Uruguay ranks 93rd of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Uruguay, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 84.04 | — |
| 2018 | 88.12 | +4.9% |
| 2019 | 79.12 | -10.2% |
| 2020 | 80.13 | +1.3% |
| 2021 | 80.19 | +0.1% |
Uruguay compared with similar countries
- Uruguay's 80.19 is below the median for high income countries, which is 92.6, 87% of the median. (56 countries reporting)
- Uruguay's 80.19 is above the median for Latin America & Caribbean, which is 59.38, 1.4× the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 83.76 | 79.12 | 88.12 | 3 |
| 2020s | 80.16 | 80.13 | 80.19 | 2 |
Countries ranked near Uruguay
More health data for Uruguay
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6727 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,631 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.79 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0241 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.84 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Uruguay?
- The number of people with susceptibility test result for rifampicin in Uruguay was 80.19 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Uruguay?
- The highest recorded value was 88.12 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Uruguay?
- The lowest recorded value was 79.12 in 2019.
- How does Uruguay rank for the number of people with susceptibility test result for rifampicin?
- Uruguay ranks 93rd out of 146 countries with data for 2021.
- Where does this Uruguay data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).